Mankind Pharma Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 24,410.99 million compared to INR 20,526.67 million a year ago. Revenue was INR 25,332.27 million compared to INR 21,001.78 million a year ago. Net income was INR 4,712.39 million compared to INR 2,854.39 million a year ago. Basic earnings per share from continuing operations was INR 11.76 compared to INR 7.13 a year ago. Diluted earnings per share from continuing operations was INR 11.74 compared to INR 7.13 a year ago.
For the full year, sales was INR 103,347.75 million compared to INR 87,494.33 million a year ago. Revenue was INR 106,156.33 million compared to INR 88,780 million a year ago. Net income was INR 19,128.97 million compared to INR 12,818.59 million a year ago. Basic earnings per share from continuing operations was INR 47.75 compared to INR 32 a year ago. Diluted earnings per share from continuing operations was INR 47.68 compared to INR 32 a year ago.